Gross Margin - Accelerate Diagnostics Inc (NASDAQ:AXDX) - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.476 USD 0.41%
Market Cap: 34.9m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Gross Margin
Accelerate Diagnostics Inc

27.2%
Current
31%
Average
47.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.2%
=
Gross Profit
3.3m
/
Revenue
12.2m

Gross Margin Across Competitors

Country US
Market Cap 34.8m USD
Gross Margin
27%
Country US
Market Cap 198.5B USD
Gross Margin
55%
Country US
Market Cap 173.7B USD
Gross Margin
67%
Country US
Market Cap 138.8B USD
Gross Margin
64%
Country US
Market Cap 124B USD
Gross Margin
69%
Country IE
Market Cap 114.6B USD
Gross Margin
66%
Country US
Market Cap 67.7B USD
Gross Margin
45%
Country DE
Market Cap 55.7B EUR
Gross Margin
38%
Country US
Market Cap 42.9B USD
Gross Margin
60%
Country US
Market Cap 40.8B USD
Gross Margin
77%
Country US
Market Cap 41.3B USD
Gross Margin
41%

Profitability Report

View the profitability report to see the full profitability analysis for Accelerate Diagnostics Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.2%
=
Gross Profit
3.3m
/
Revenue
12.2m
What is the Gross Margin of Accelerate Diagnostics Inc?

Based on Accelerate Diagnostics Inc's most recent financial statements, the company has Gross Margin of 27.2%.